Roche buys Ventana in $3.4 billion deal

Roche said Tuesday it will pay $3.4 billion to purchase US-based drug testing instrument maker Ventana Medical Systems.

Stephen McGuire

January 22, 2008

5:00 am

Roche said Tuesday it will pay $3.4 billion to purchase US-based drug testing instrument maker Ventana Medical Systems.

Ventana will keep its headquarters in Tucson, AZ, while its CEO Christopher Gleeson will join the board of Roche’s diagnostics division, the companies said in a statement.

Wall Street analysts said the offer from Roche came as no surprise as the Swiss drugmaker has been trying to take over Ventana since June, and extended offers five times before clinching the deal.

Ventana currently employs 800 people and in 2006 had $238.2 million in sales of chemicals and instrument used to automatically prepare tissue samples for cancer screening and the testing of new drugs.

From Our Partners

Taking a patient-centric approach to privacy

Partner Content

Taking a patient-centric approach to privacy

This podcast will explore ways to deliver tailored content that activates, educates and empowers patients while prioritizing privacy and consent.

Living brands: How to build brands in the age of omnichannel

Partner Content

Living brands: How to build brands in the age of omnichannel

This podcast looks at how to leverage advancements in data, technology, AI and content development in order to become a Living Brand.

Partner Content

The new brand.com experience

How healthcare manufacturers can improve customer engagement, drive high-value activity and inform future strategy with conversational AI.

Shifting market trends are transforming how pharma marketers find, target and engage with patients and providers

Partner Content

Shifting market trends are transforming how pharma marketers find, target and engage with patients and providers

The Healthcare Marketers Trend Survey shows that, as far as channel usage goes, more growth occurred in newer tactics like non-linear video and streaming audio than in some of the more traditional ones.